Table 2.
Overview of diagnostic methods for the detection of monkeypox virus
| Method | Description | Strengths | Limitations | References |
|---|---|---|---|---|
| Polymerase chain reaction (PCR) | Molecular detection of MPXV DNA, targeting specific genes | High sensitivity and specificity; gold standard | Requires advanced labs and trained personnel | [76] |
| Next-generation sequencing (NGS) | Comprehensive genomic sequencing of MPXV for clade identification | Detects mutations; tracks viral evolution | High cost; complex analysis; time-intensive | [77, 78] |
| serology (ELISA) | Detects antibodies against MPXV in patient samples | Useful for epidemiological studies | Cross-reactivity with other Orthopoxviruses; limited for acute diagnosis | [79] |
| Rapid diagnostic tests (RDTs) | Lateral flow assays for antigen or antibody detection | Portable; quick results | Lower sensitivity compared to PCR | [80, 81] |
| Loop-Mediated Isothermal Amplification (LAMP) | Isothermal amplification of MPXV DNA | Portable; fast; field deployable | Lower sensitivity and specificity than PCR | [80, 81] |
| Clinical diagnosis | Based on characteristic symptoms, such as fever, rash, and lymphadenopathy | Useful in resource-limited settings | Overlaps with other illnesses; relies on clinician expertise | [82] |
| Viral culture | Isolation of live virus in cell culture | Confirms live virus presence | Requires BSL-3 labs; time-consuming | [82] |
| CRISPR-based assays | Uses CRISPR-Cas systems for precise nucleic acid detection | Highly specific, portable | Emerging technology; limited availability | [83, 84] |
| Recombinase polymerase amplification (RPA) | Isothermal DNA amplification at ~ 37–42 °C; results in ~ 15–20 min | Ultra-rapid; portable; suitable for low-resource settings | Still under optimization; risk of cross-contamination | [85] |